LVCLY

Living Cell Technologies Ltd.

 
Sponsored ADR (1 ADS : 10 Ordinary)
PAL: BNY Mellon OTCQX International

OTC Disclosure & News Service

Release Date Title Type
May 17, 2012 LCT's DIABECELL trial extension approved Press Release
May 04, 2012 Home Country News Release - Change of Directors Interest Notice Financial Report News Release
May 03, 2012 Home Country News Release - Appendix 3B Financial Report News Release
May 02, 2012 Cleansing Statement Press Release
Apr 30, 2012 LCT's Share Purchase Plan successful Press Release
Apr 16, 2012 Dr Barry Snow to lead Parkinson's trial for LCT Press Release
Mar 30, 2012 Home Country News Release - Share Purchase Plan Documents - open to Australian and New Zealand shareholders Financial Report News Release
Mar 20, 2012 LCT Presents Novel Parkinson's Disease Treatment Results Press Release
Mar 19, 2012 LCT announces Share Purchase Plan Press Release
Feb 28, 2012 LCT granted E.U. Patent for tissue engineering Press Release
Feb 27, 2012 LCT completes pre-clinical studies of NTCELL in Parkinson's Press Release
Feb 17, 2012 Home Country News Release - Price query response Financial Report News Release
Feb 01, 2012 LCT granted USA Patent for Auckland Island Pigs Press Release
Dec 31, 2011 Home Country News Release - Half Yearly Report and Accounts Financial Report News Release
Dec 27, 2011 LCT appoints Chief Executive Press Release
Dec 13, 2011 Home Country News Release - Change of Directors Interest Notice Financial Report News Release
Dec 13, 2011 Home Country News Release - Change of Directors Interest Notice Financial Report News Release
Dec 13, 2011 Home Country News Release - Change of Directors Interest Notice Financial Report News Release
Dec 05, 2011 Home Country News Release - Change of Directors Interest Notice Financial Report News Release
Nov 30, 2011 Home Country News Release - Amended AGM Poll Result Financial Report News Release